Prometheus Biosciences Buy Hold or Sell Recommendation
| RXDXDelisted Stock | USD 199.92 0.24 0.12% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Prometheus Biosciences is 'Not Rated'. Macroaxis provides Prometheus Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RXDX positions. The advice algorithm takes into account all of Prometheus Biosciences' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Prometheus Biosciences' buy or sell advice are summarized below:
Real Value 150.07 | Hype Value 199.92 | Market Value 199.92 | Naive Value 190.64 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Prometheus Biosciences given historical horizon and risk tolerance towards Prometheus Biosciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Prometheus Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Prometheus |
Execute Prometheus Biosciences Buy or Sell Advice
The Prometheus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Prometheus Biosciences. Macroaxis does not own or have any residual interests in Prometheus Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Prometheus Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Prometheus Biosciences Trading Alerts and Improvement Suggestions
| Prometheus Biosciences is not yet fully synchronised with the market data | |
| Prometheus Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.81 M. Net Loss for the year was (141.75 M) with loss before overhead, payroll, taxes, and interest of (106.04 M). | |
| Prometheus Biosciences currently holds about 95.96 M in cash with (123.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.35. | |
| Over 81.0% of the company shares are owned by institutional investors |
Prometheus Biosciences Returns Distribution Density
The distribution of Prometheus Biosciences' historical returns is an attempt to chart the uncertainty of Prometheus Biosciences' future price movements. The chart of the probability distribution of Prometheus Biosciences daily returns describes the distribution of returns around its average expected value. We use Prometheus Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Prometheus Biosciences returns is essential to provide solid investment advice for Prometheus Biosciences.
| Mean Return | 1.04 | Value At Risk | -3.26 | Potential Upside | 2.76 | Standard Deviation | 8.71 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Prometheus Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 178098 shares by Mark McKenna of Prometheus Biosciences subject to Rule 16b-3 [view details]
Prometheus Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Prometheus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Prometheus Biosciences Buy or Sell Advice
When is the right time to buy or sell Prometheus Biosciences? Buying financial instruments such as Prometheus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Prometheus Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Government Funds Thematic Idea Now
Government Funds
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Prometheus Biosciences information on this page should be used as a complementary analysis to other Prometheus Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |